# OnCo record apt-trial (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/apt-trial/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "apt-trial", "NCT00542451" ;
  schema:name "APT (adjuvant paclitaxel-trastuzumab)"@en ;
  schema:description "For small HER2-positive tumours, a gentle regimen of weekly paclitaxel plus trastuzumab gives excellent cure rates, avoiding harsher chemotherapy."@en ;
  schema:url <https://onco.cc/trials/apt-trial/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00542451> ;
  onco:status "positive" ;
  onco:phase "2" ;
  schema:startDate "2007-10" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/her2-positive-early-breast-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/trastuzumab/> ;
  onco:people <https://onco.cc/people/sara-tolaney/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-apt-tolaney-nejm-2015/>, <https://onco.cc/key-papers/paper-apt-trial-lancet-oncol-2023-update/> .